| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
2 The Cardiovascular Institute, Michael Reese Hospital and Medical Center, Chicago 60616; 1 Department of Medicine, Cook County Hospital, Chicago, Illinois 60612; and 3 Division of Cardiology, Evangelismos General Hospital, GR-11516 Athens, Greece
The antiarrhythmic amiodarone (AM) and its metabolite desethylamiodarone (Des) are known to cause AM-induced pulmonary toxicity, but the mechanisms underlying this disorder remain unclear. We hypothesized that AM might cause AM-induced pulmonary toxicity in part through the induction of apoptosis or necrosis in alveolar epithelial cells (AECs). Two models of type II pneumocytes, the human AEC-derived A549 cell line and primary AECs isolated from adult Wistar rats, were incubated with AM or Des for 20 h. Apoptotic cells were determined by morphological assessment of nuclear fragmentation with propidium iodide on ethanol-fixed cells. Necrotic cells were quantitated by loss of dye exclusion. Both AM and Des caused dose-dependent necrosis starting at 2.5 and 0.1 µg/ml, respectively, in primary rat AECs and at 10 and 5 µg/ml in subconfluent A549 cells (P < 0.05 and P < 0.01, respectively). AM and Des also induced dose-dependent apoptosis beginning at 2.5 µg/ml in the primary AECs (P < 0.05 for both compounds) and at 10 and 5 µg/ml, respectively, in the A549 cell line (P < 0.01). The two compounds also caused significant net cell loss (up to 80% over 20 h of incubation) by either cell type at drug concentrations near or below the therapeutic serum concentration for AM. The cell loss was not due to detachment but was blocked by the broad-spectrum caspase inhibitor Z-Val-Ala-Asp-fluoromethylketone. Furthermore, the angiotensin-converting enzyme inhibitor captopril (500 ng/ml) and the angiotensin-receptor antagonist saralasin (50 µg/ml) significantly inhibited both the induction of apoptosis and net cell loss in response to AM. These results are consistent with recent work from this laboratory demonstrating potent inhibition of apoptosis in human AECs by captopril (Uhal BD, Gidea C, Bargout R, Bifero A, Ibarra-Sunga O, Papp M, Flynn K, and Filippatos G. Am J Physiol Lung Cell Mol Physiol 275: L1013-L1017, 1998). They also suggested that the accumulation of AM and/or its primary metabolite Des in lung tissue may induce cytotoxicity of AECs that might be inhibitable by angiotensin-converting enzyme inhibitors or other antagonists of the renin-angiotensin system.
captopril; desethylamiodarone; type II pneumocyte; angiotensin-converting enzyme inhibitor
This article has been cited by other articles:
|
|
 |
|
  B. D. Uhal The role of apoptosis in pulmonary fibrosis Eur. Respir. Rev., December 1, 2008; 17(109): 138 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hammerschmidt, H. Kuhn, C. Gessner, H.-J. Seyfarth, and H. Wirtz Stretch-Induced Alveolar Type II Cell Apoptosis: Role of Endogenous Bradykinin and PI3K-Akt Signaling Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 699 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, R. Shu, G. Filippatos, and B. D. Uhal Apoptosis in lung injury and remodeling J Appl Physiol, October 1, 2004; 97(4): 1535 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, H. Zhang, V. Soledad-Conrad, J. Zhuang, and B. D. Uhal Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L501 - L507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Baritussio, S. Marzini, M. Agostini, A. Alberti, C. Cimenti, D. Bruttomesso, E. Manzato, D. Quaglino, and A. Pettenazzo Amiodarone inhibits lung degradation of SP-A and perturbs the distribution of lysosomal enzymes Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1189 - L1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Filippatos, N. Gangopadhyay, O. Lalude, N. Parameswaran, S. I. Said, W. Spielman, and B. D. Uhal Regulation of apoptosis by vasoactive peptides Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L749 - L761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Dincer, N. Gangopadhyay, R. Wang, and B. D. Uhal Norepinephrine induces alveolar epithelial apoptosis mediated by {alpha}-, {beta}-, and angiotensin receptor activation Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L624 - L630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fine, Y. Janssen-Heininger, R. P. Soultanakis, S. G. Swisher, and B. D. Uhal Apoptosis in lung pathophysiology Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L423 - L427. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
